For COVID-19 vaccine updates, please review our information guide. For patient eligibility and scheduling availability, please visit

News and Events

As has been previously announced, 2018 saw the departure of long time Administrative Director, Dr. Ruth Gotian. Though we took the news with heavy hearts, we are excited to see Ruth move on to new and exciting positions here at Weill Cornell Medicine.
In August of 2018, Catharine Boothroyd, PhD, joined Tri-I as the new Administrative Director. This marks the beginning of an exciting new era for the Program and a return to the Tri-Institutional campus for Catharine, who earned her PhD and did a post-doc at Rockefeller.From Dr. Boothroyd:
The results of the 2019 Residency Match Day were overwhelmingly positive for the Tri-Institutional MD-PhD graduating students who entered the Match. All eight of them were matched at some of the most prestigious programs and leading hostpitals in the country. Below we list the graduates with the field and institution of their residency. 
The U.S. News & World Report rankings of Best Medical Schools 2019-2020 places Weill Cornell Medical College ninth overall for Best Medical Schools: Research.For the full list of ranked medical schools and more information, see the original article here. 
Barbara "Bobbie" Pelham-Webb, currently in her fifth year in the Tri-Institutional MD-PhD Program, has been awarded an F30 Fellowship from the National Institute of Healths' Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).
Professor Barbara Kazmierczak, MD, PhD (Tri-Institutional MD-PhD class of 1994), who currently is professor of medicine (infectious diseases) and microbial pathogenesis, has been named the Gustavus and Louse Pfeiffer Research Foundation MD-PhD Program Director at the Yale School of Medicine.
Third year Tri-Institutional MD-PhD student Dianne Lumaquin has been names as the recipient of a Medical Student Award from the Melanoma Research Foundation. 
In 2013, scientists at MIT and at UC Berkeley optimized a way to use bacterial gene sequences to cut and change DNA at precise locations. The genome-editing system, called CRISPR, is cheaper and simpler than previous methods, and it has led to breakthroughs in diagnostics and the creation of more accurate disease models.
Fifth year Tri-Instutional MD-PhD student, Jay Shi, has been awarded an F30 fellowship from the National Institutes of Health's National Cancer Institute for his project "Dynamic Organization of Cell Architecture in Multicellular Tissues."
Joshua Weiss, a fifth year student in the Tri-Institutional MD-PhD Program, has been awarded an NIH F30 fellowship from the National Cancer Institute for his project "Investigating the Role of Adipocyte Lipolysis in Melanoma Progression.”